Patent Assignment
Reel/Frame 025184/0666
Change of Name
Recorded: 2010-10-22
Received: 2010-10-22
Pages: 7
Assignor
WYETH
Executed: 2009-11-09
Assignee
WYETH LLC
FIVE GIRALDA FARMS, MADISON, NJ, 07940, UNITED STATES
Covered Properties
(16)
Treatment of amyloidogenic diseases
Application:
60/793,014 →
Humanized antibodies that recognize beta amyloid peptide
Application:
11/396,417 →
Contextual fear conditioning for predicting immunotherapeutic efficacy
Application:
60/736,119 →
Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
Application:
60/736,045 →
Beta antibodies for use in improving cognition
Application:
60/735,687 →
Methods of purifying Fc region containing proteins
Application:
60/691,821 →
Abeta antibodies for use in improving cognition
Application:
60/637,138 →
Contextual fear conditioning for predicting immunotherapeutic efficacy
Application:
60/637,253 →
Abeta antibodies for use in improving cognition
Application:
60/636,810 →
Humanized antibodies that recognize beta amyloid peptide
Application:
60/636,684 →
Contextual fear conditioning for predicting immunotherapeutic efficacy
Application:
60/636,842 →
Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
Application:
60/636,687 →
Methods for assessing antibodies to neurodegenerative disease-associated antigens
Application:
60/622,525 →
Methods and compositions for eliminating intron read-through in recombinant protein expression
Application:
60/616,474 →
Humanized antibodies that recognize beta amyloid peptide
Application:
60/474,654 →
Humanized antibodies that recognize beta amyloid peptide
Application:
60/363,751 →